Movatterモバイル変換


[0]ホーム

URL:


GB9615942D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9615942D0
GB9615942D0GBGB9615942.1AGB9615942AGB9615942D0GB 9615942 D0GB9615942 D0GB 9615942D0GB 9615942 AGB9615942 AGB 9615942AGB 9615942 D0GB9615942 D0GB 9615942D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9615942.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AGfiledCriticalSandoz AG
Priority to GBGB9615942.1ApriorityCriticalpatent/GB9615942D0/en
Publication of GB9615942D0publicationCriticalpatent/GB9615942D0/en
Priority to ES01131018Tprioritypatent/ES2270948T3/en
Priority to DE69736750Tprioritypatent/DE69736750T2/en
Priority to JP50851398Aprioritypatent/JP3942641B2/en
Priority to ES97937526Tprioritypatent/ES2182112T3/en
Priority to SI9730389Tprioritypatent/SI0956034T1/en
Priority to DK01131018Tprioritypatent/DK1208847T3/en
Priority to AU40124/97Aprioritypatent/AU730781B2/en
Priority to PT97937526Tprioritypatent/PT956034E/en
Priority to AT97937526Tprioritypatent/ATE222502T1/en
Priority to SI9730756Tprioritypatent/SI1208847T1/en
Priority to DK97937526Tprioritypatent/DK0956034T3/en
Priority to EP01131018Aprioritypatent/EP1208847B8/en
Priority to US09/230,618prioritypatent/US6239124B1/en
Priority to EP97937526Aprioritypatent/EP0956034B1/en
Priority to DE69714861Tprioritypatent/DE69714861T2/en
Priority to AT01131018Tprioritypatent/ATE340586T1/en
Priority to CA2261666Aprioritypatent/CA2261666C/en
Priority to NZ333657Aprioritypatent/NZ333657A/en
Priority to PCT/EP1997/004123prioritypatent/WO1998004279A1/en
Priority to PT01131018Tprioritypatent/PT1208847E/en
Priority to HK00102877Aprioritypatent/HK1023720A1/en
Priority to US09/758,301prioritypatent/US6455518B2/en
Priority to CY0300086Aprioritypatent/CY2391B1/en
Priority to JP2003408898Aprioritypatent/JP4149905B2/en
Pendinglegal-statusCriticalCurrent

Links

GBGB9615942.1A1996-07-301996-07-30Organic compoundsPendingGB9615942D0 (en)

Priority Applications (25)

Application NumberPriority DateFiling DateTitle
GBGB9615942.1AGB9615942D0 (en)1996-07-301996-07-30Organic compounds
PT01131018TPT1208847E (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
EP01131018AEP1208847B8 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
EP97937526AEP0956034B1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
JP50851398AJP3942641B2 (en)1996-07-301997-07-29 Pharmaceutical composition for the treatment of transplant rejection, autoimmune disease or inflammatory condition comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin
ES97937526TES2182112T3 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THE REJECTION OF TRANSPLANTS AND OF AUTOIMMUNE OR INFLAMMATORY STATES, THAT INCLUDE CYCLOSPORIN A AND 40-O- (2-HYDROXYETHYL) -RAPAMICINE.
SI9730389TSI0956034T1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
DK01131018TDK1208847T3 (en)1996-07-301997-07-29 Pharmaceuticals for the treatment of graft rejection as well as autoimmune or inflammatory conditions
AU40124/97AAU730781B2 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxiethyl)-rapamycin
PT97937526TPT956034E (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION OF INFLAMMATORY OR AUTO-IMMUNE STATES COMPOSING CYCOSPORINE E 40-O- (2-HYDROXYETHYL) -RAPAMICINE
AT97937526TATE222502T1 (en)1996-07-301997-07-29 COMBINATION PREPARATION WITH AN INHIBITANT EFFECT ON TRANSPLANT REJECTION, AUTOIMMUNE DISEASES AND INFLAMMATION, CONTAINING CYCLOSPORIN A AND 40-0-(2-HYDROXYETHYL)-RAPAMYCIN
SI9730756TSI1208847T1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
DK97937526TDK0956034T3 (en)1996-07-301997-07-29 Pharmaceutical compositions for the treatment of graft rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin
ES01131018TES2270948T3 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AS WELL AS THE AUTOIMMUNE OR INFLAMMATORY CONDITIONS.
US09/230,618US6239124B1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin
DE69736750TDE69736750T2 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT DISPOSAL AND AUTOIMMUNE OR INFLAMMABLE CONDITIONS
DE69714861TDE69714861T2 (en)1996-07-301997-07-29 COMBINATION PRODUCT WITH AN INHIBITING EFFECT ON REPELLATION OF TRANSPLANTS, AUTOIMMUNE DISEASES AND INFLAMMATION, WHICH CONTAINS CYCLOSPORIN A AND 40-0- (2-HYDROXYETHYL) -RAPAMYCIN
AT01131018TATE340586T1 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION AND AUTOIMMUNE OR INFLAMMATORY CONDITIONS
CA2261666ACA2261666C (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
NZ333657ANZ333657A (en)1996-07-301997-07-29A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin
PCT/EP1997/004123WO1998004279A1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
HK00102877AHK1023720A1 (en)1996-07-302000-05-15Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
US09/758,301US6455518B2 (en)1996-07-302001-01-11Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin
CY0300086ACY2391B1 (en)1996-07-302003-11-28Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin.
JP2003408898AJP4149905B2 (en)1996-07-302003-12-08 Pharmaceutical composition for the treatment of transplant rejection, autoimmune disease or inflammatory condition comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB9615942.1AGB9615942D0 (en)1996-07-301996-07-30Organic compounds

Publications (1)

Publication NumberPublication Date
GB9615942D0true GB9615942D0 (en)1996-09-11

Family

ID=10797708

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB9615942.1APendingGB9615942D0 (en)1996-07-301996-07-30Organic compounds

Country Status (1)

CountryLink
GB (1)GB9615942D0 (en)

Similar Documents

PublicationPublication DateTitle
GB9604926D0 (en)Organic compounds
GB9604816D0 (en)Organic compounds
GB9603446D0 (en)Organic compounds
GB9603237D0 (en)Organic compounds
GB9604924D0 (en)Organic compounds
GB9604412D0 (en)Organic compounds
GB9601749D0 (en)Organic compounds
GB9602494D0 (en)Organic compounds
GB9602824D0 (en)Organic compounds
GB9603100D0 (en)Organic compounds
GB9601297D0 (en)Organic compounds
GB9601294D0 (en)Organic compounds
GB9603776D0 (en)Organic compounds
GB9603988D0 (en)Organic compounds
GB9603993D0 (en)Organic compounds
GB9604070D0 (en)Organic compounds
GB9604406D0 (en)Organic compounds
GB9604407D0 (en)Organic compounds
GB9604408D0 (en)Organic compounds
GB9605793D0 (en)Organic compounds
GB9604651D0 (en)Organic compounds
GB9601121D0 (en)Organic compounds
GB9604923D0 (en)Organic compounds
GB9615942D0 (en)Organic compounds
GB9604925D0 (en)Organic compounds

Legal Events

DateCodeTitleDescription
730Substitution of applicants allowed (sect. 30/1977)

[8]ページ先頭

©2009-2025 Movatter.jp